NCT01877512View on ClinicalTrials.gov

GH and Cardiovascular Risk Factors

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Growth Hormone DeficiencyCardiovascular DiseasesMetabolic SyndromeCognitionPhysical Activity
Interventions
DRUG

Change in daily dosage of Growth Hormone

Trial Locations (1)

1007 MB

VU University Medical Center, Amsterdam

All Listed Sponsors
lead

Amsterdam UMC, location VUmc

OTHER

NCT01877512 - GH and Cardiovascular Risk Factors | Biotech Hunter | Biotech Hunter